170 related articles for article (PubMed ID: 27698202)
21. Laboratory assessment of disappearance patterns of human chorionic gonadotropin from serum of patients with gestational trophoblastic disease.
Boots LR; Hatch KD; Younger JB
Ala J Med Sci; 1983 Oct; 20(4):391-4. PubMed ID: 6316799
[No Abstract] [Full Text] [Related]
22. Complete hydatidiform mole with coexisting normal fetus-report of two cases.
Margolis K; Maher M; Sidhu M
Aust N Z J Obstet Gynaecol; 1999 Nov; 39(4):511-3. PubMed ID: 10687779
[No Abstract] [Full Text] [Related]
23. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
24. The level of beta-subunit of human chorionic gonadotrophin in benign hydatidiform mole.
Tangtakul S; Srisupundit S
J Med Assoc Thai; 1988 Mar; 71 Suppl 1():111-3. PubMed ID: 2458424
[No Abstract] [Full Text] [Related]
25. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
[TBL] [Abstract][Full Text] [Related]
26. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
27. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
28. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound in early pregnancy complications.
Coleman BG; Arger PH
Clin Obstet Gynecol; 1988 Mar; 31(1):3-18. PubMed ID: 2452044
[No Abstract] [Full Text] [Related]
30. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
[TBL] [Abstract][Full Text] [Related]
31. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus and pregnancy: A case report.
Malatyalioglu E; Kurtoglu E; Kokcu A; Ozdemir AZ
J Obstet Gynaecol; 2015 Apr; 35(3):302-3. PubMed ID: 25111029
[No Abstract] [Full Text] [Related]
33. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
[TBL] [Abstract][Full Text] [Related]
34. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
35. Partial hydatidiform mole in the fallopian tube.
Terada S; Suzuki N; Uchide K; Akasofu K
Gynecol Obstet Invest; 1993; 35(4):240-2. PubMed ID: 7687230
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
37. Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles.
Dawood MY
Am J Obstet Gynecol; 1974 Aug; 119(7):911-8. PubMed ID: 4366792
[No Abstract] [Full Text] [Related]
38. Level of hCG for considering an ectopic pregnancy.
Pruiksma R
Am Fam Physician; 2006 Apr; 73(8):1331; author reply 1331. PubMed ID: 16669555
[No Abstract] [Full Text] [Related]
39. Postchemotherapy late recurrence of non metastatic gestational trophoblastic disease following a partiale mole. A case report.
Prosperi Porta R; Cavazzana AO; Coppola S; Franco C; Camilli A; Patella A
Eur J Gynaecol Oncol; 2000; 21(4):403-4. PubMed ID: 11055495
[TBL] [Abstract][Full Text] [Related]
40. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
